Toxicology is the investigation of the unfriendly impacts of substance, physical, or natural specialists on living beings and the biological system, including the counteractive action and enhancement of such antagonistic impacts. Established in 1961, the Society of Toxicology (SOT) is an expert and insightful association of researchers from scholastic foundations, government, and industry speaking to the immense assortment of researchers who hone toxicology in the US and abroad. The Society's main goal is to make a more secure and more beneficial world by propelling the science and expanding the effect of toxicology.
Society of Toxicology works under the directing standards of serving the requirements of the investigative control and our individuals to improve human, creature, and natural wellbeing, deep rooted learning and scholarly logical incitement, differing qualities of representation in all exercises of the Society and trustworthiness.
Society of Toxicology is focused on assorted qualities and comprehensiveness in the majority of its exercises. We declare that differing qualities and comprehensiveness incorporate numerous elements, for example, sex, race/ethnicity, work segment, nationality, geographic area, physical capacity, and investigative skill and point of view. Grasping differing qualities and streamlining incorporation augments the scope of inventiveness and development in our Society and our science. SOT leadership has adopted a tactical plan designed to enhance the core functions of the Society—providing forums for scientific exchange, mission, and guiding values. Every March, around 7000 toxicologists and 400 exhibitors attend the SOT Annual Meeting and ToxExpo, the largest gathering of industry, governmental, and academic toxicologists in the world. In 2017, the 56th Annual Meeting.
Dr. John B. Morris is the President (2016–2017) and a Board of Trustees. He has been on the faculty of the Toxicology Program for 32 years and served as the director of the program from 2000–2010. He served as the head of the Pharmaceutical Sciences Department (2002–2010), and is currently completing his period as interim dean of the School of Pharmacy at the University.